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1. Introduction
The use of nucleic acids to replace defective genes or silence
aberrant ones is an attractive strategy for the treatment of ge-
netic disorders. However, the development of efficient and safe
materials that can deliver therapeutic nucleic acids to the tar-
get cells of a patient is an enormous challenge. Both viral and
non-viral nucleic acid delivery systems, such as cationic lipo-
somes and cationic polymers, which electrostatically bind to
negatively charged nucleic acids, are currently being investi-
gated.[1] Unfortunately, the former system is plagued by safety
issues,[2] whereas the latter systems are vulnerable to non-spe-
cific interactions with blood compounds due to their positive
surface charge, resulting in the formation of life-threatening
aggregates and suffering from rapid clearance by the mononu-
clear phagocyte system.[3,4] These unwanted interactions have
been prevented by coating the non-viral gene delivery systems
with non-fouling polymers like poly(ethylene glycol) (PEG).[5]
However, ‘PEGylation’ drastically reduces the transfection ef-
ficacy of non-viral gene delivery systems, which has been at-
tributed to reduced cellular uptake and/or limited endosomal
escape.[6,7] To overcome these limitations, the use of ultrasound
energy in combination with gas-filled microbubbles has re-
cently been proposed.[8–14] Ultrasound may mediate the intra-
cellular delivery of nucleic acids by the formation of small (100
to a few hundreds of nanometers large) transient pores in cell
membranes.[15,16] These cell perforations are caused by shock-
waves and microjets that are generated by the ultrasound-in-
duced implosion of microbubbles in the vicinity of the cell
membranes. The lifetimes of the cell membrane perforations
have been reported to be very short, in the millisecond to sec-
onds range.[15–17] Therefore, we believe that the binding of
nanoparticles to microbubbles will allow the particles to be
present at the site of cell membrane perforation, which may en-
hance the number of nanoparticles that can enter the cell. In
this study, we have attempted to load PEGylated lipoplexes
onto microbubbles to overcome their low transfection efficien-
cy. Furthermore, the coupling of liposomes to microbubbles
could be an interesting approach for the ultrasound-induced re-
lease of different types of therapeutic molecules.
2. Results and Discussion
2.1. Preparation and Characterization of Lipoplex-Loaded
Microbubbles
As schematically illustrated in Figure 1A, PEGylated lipo-
plexes, i.e., complexes of DNA with cationic PEGylated
liposomes (Fig. 1B), have been attached to microbubbles via
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Cationic poly(ethylene glycol)ylated (PEGylated) liposomes are one of the most important gene transfer reagents in non-viral
gene therapy. However, the low transfection efficiencies of highly PEGylated lipoplexes currently hamper their clinical use.
Recently, ultrasound has been used in combination with microbubbles to enhance the uptake of genes in different cell types.
However, the gene transfer efficiency still remains low in these experiments. To overcome the limitations of both techniques,
we present the attachment of PEGylated lipoplexes to microbubbles via biotin–avidin–biotin linkages. Exposure of these lipo-
plex-loaded microbubbles to ultrasound results in the release of unaltered lipoplexes. Furthermore, these lipoplex-loaded
microbubbles exhibit much higher transfection efficiencies than “free” PEGylated lipoplexes or naked plasmid DNA (pDNA)
when combined with microbubbles and ultrasound. Interestingly, the lipoplex-loaded microbubbles only transfect cells when
exposed to ultrasound, which is promising for space- and time-controlled gene transfer. Finally, this novel Trojan-horse-like
concept can also be exploited to achieve the ultrasound-triggered release of nanoparticles containing other therapeutic agents
such as anticancer drugs.
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biotin–avidin–biotin bridges. To prepare these lipoplex-loaded
microbubbles, we have used lipid-based microbubbles that con-
tain 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[bio-
tinyl-PEG-2000] (DSPE–PEG–biotin) in their lipid shell. To
evaluate whether the biotin molecules are present on the outer
surface of the microbubbles, we have incubated them with
Cy5-labeled avidin. After removing the free Cy5–avidin, confo-
cal laser scanning microscopy (CLSM) clearly reveals the pres-
ence of red fluorescence around the microbubbles, indicating
the formation of a biotin–avidin linkage (Fig. 2). This confirms
that the DSPE–PEG–biotin molecules in the shell of the
microbubbles are oriented with their hydrophobic
tails pointing to the perfluorobutane gas core and
with their hydrophilic head groups in the aqueous
medium, as previously suggested by Unger et al.[18]
To determine whether the biotinylated microbubbles
have an optimal size distribution for cavitation, we
have studied their size distribution by laser diffrac-
tion (Fig. 3, solid circles). As shown in Figure 3, the
microbubbles are between 0.5 and 10 lm in size,
which is indeed optimal for cavitation upon exposure
to clinically relevant ultrasound irradiation.[18] To en-
able the binding of the PEGylated lipoplexes to the
biotin-containing microbubbles, we have first incu-
bated the microbubbles with an excess of avidin.
After removing the unbound avidin, PEGylated
lipoplexes containing increasing amounts of
DSPE–PEG–biotin (2, 5, and 15 mol%) are added
to the microbubbles. Figure 4 demonstrates the bind-
ing of fluorescently-labeled PEGylated lipoplexes to
the microbubbles. We observe that all the micro-
bubbles have attached lipoplexes on their surface in-
dependent of the percentage of DSPE–PEG–biotin
in the lipoplexes, indicating that the number of lipo-
plexes greatly exceeds the number of microbubbles.
The amount of DSPE–PEG–biotin in the PEGylated
lipoplexes clearly effects on the number of lipoplexes
bound per microbubble. Lipoplexes containing
2 mol% DSPE–PEG–biotin do not completely cover
the surface of the microbubbles, likely because of the
limited degree of biotinylation of the lipoplexes. The
surfaces of most microbubbles are fully covered with
PEGylated lipoplexes when 5 mol% DSPE–PEG–
biotin is incorporated in the lipoplexes, whereas all
the microbubbles are completely covered with PEG-
ylated lipoplexes when lipoplexes containing
15 mol% DSPE–PEG–biotin are used. The inset to
Figure 4B shows a high-magnification image of a
single lipoplex-loaded microbubble. To determine
the effect of lipoplex binding on the size of the
microbubbles, we have also measured the size distri-
bution of the microbubbles after incubation with the
biotinylated lipoplexes (Fig. 3, solid squares). Com-
pared to the unloaded microbubbles, the lipoplex-
loaded microbubbles are slightly smaller, which is
probably due to experimental variations such as
localization of the sonication probe and removal of the subna-
tant during successive washing steps. To confirm that the lipo-
plexes are specifically bound to the microbubbles through
avidin–biotin interactions, we have tested the binding of PEG-
ylated lipoplexes lacking biotin. The lipoplexes used in this
control experiment contain 5 mol% DSPE–PEG instead of
DSPE–PEG–biotin. The moderate binding of these non-bio-
tinylated lipoplexes to the microbubbles is observed (data not
shown). Since avidin is a glycosylated protein, non-specific in-
teractions with different types of molecules and particulate
matter can be expected.
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Figure 1. A) Schematic depiction of a lipoplex-loaded microbubble. The white disk
surrounded by the lipids, dipalmitoylphosphatidylcholine (DPPC) and 1,2-distearoyl-
sn-glycero-3-phosphoethanolamine-N-[biotinyl-PEG-2000] (DSPE–PEG–biotin), repre-
sents an avidinylated lipid microbubble with a perfluorobutane (C4F10) gas core.
Lipoplexes with increasing amounts of DSPE–PEG–biotin are attached to these avidi-
nylated microbubbles via biotin–avidin–biotin bridges. B) Detailed illustration of a
single biotinylated lipoplex. DOTAP: N-(1-(2,3-dioleoyloxy)propyl)-N,N,N-trimethylam-
monium chloride; DOPE: dioleoyl phosphatidyl ethanolamine.
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2.2. Ultrasound-Induced Release of PEGylated Lipoplexes
from Microbubbles
As mentioned in Section 1, the exposure of microbubbles to
ultrasound causes the implosion and hence destruction of the
microbubbles. Consequently, nanoparticles that are attached to
the lipid-based microbubbles can be released from the micro-
bubbles by ultrasound. Lum et al.[19] have succeeded in attach-
ing latex beads to lipid microbubbles, and have demonstrated
the release of these beads under ultrasonic treatment. How-
ever, in contrast to inert beads, lipoplexes, which arise from the
self-assembly of cationic liposomes and DNA, may undergo
physicochemical alterations (which can possibly reduce their
biological performance) during ultrasound-triggered release
from the microbubbles. Therefore, some physicochemical prop-
erties of the lipoplexes have been measured before attachment
to the microbubbles and after ultrasound-triggered release
from the microbubbles. The size of the free lipoplexes has been
measured using dynamic light scattering (DLS). The lipoplexes
decrease in size (from ca. 325 to 125 nm) with increasing
degree of PEGylation. No significant difference in size is
observed after the ultrasound-induced release of the lipoplexes
from the microbubbles, except that the lipoplexes prepared
with 15 mol% DPPC–PEG–biotin become slightly larger
(Fig. 5). The zeta potential before attachment to the microbub-
bles is around 25 mV for lipoplexes containing 2 mol%
DSPE–PEG–biotin, around 22 mV for lipoplexes with
5 mol% DSPE–PEG–biotin, and ca. 14 mV for lipoplexes
containing 15 mol% DSPE–PEG–biotin. The zeta potential of
the lipoplexes is not significantly altered after release from the
microbubbles by ultrasound treatment (Fig. 6). Apart from the
retention of the size and zeta potential of the lipoplexes, it is
also important that they do not dissociate upon exposure to
ultrasound. Therefore, gel electrophoresis has been used to
evaluate whether the ultrasound-assisted release of lipoplexes
from the microbubbles leads to the release of plasmid DNA
(pDNA). Free pDNA is not detected before the attachment of
the lipoplexes or after the ultrasound-induced release of the
lipoplexes from the microbubbles (Fig. 7). This means that the
ultrasound-mediated implosion of the microbubbles and the in-
duced microjets do not influence the complexation properties
of the cationic liposomes.
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Figure 2. CLSM (left) and transmission (right) image of biotinylated
microbubbles after incubation with Cy5-labeled streptavidin.
0 2 4 6 8 10 12
0,0
0,2
0,4
0,6
0,8
1,0  With lipoplexes
 Without lipoplexes
F
ra
c
ti
o
n
Size (µm)
Figure 3. Size distribution of DPPC/DSPE–PEG–biotin microbubbles be-
fore and after the addition of 15 mol% PEGylated lipoplexes, as measured
by laser diffraction. The y-axis shows the abundance of a certain class of
microbubbles normalized to the most abundant fraction of microbubbles
(y= 1). The data represent the mean of three independent measurements.
Figure 4. CLSM and corresponding transmission images of avidinylated
microbubbles incubated with fluorescently labeled (green) PEGylated lipo-
plexes. The PEGylated lipoplexes contain A) 2 mol%, B) 5 mol%, and
C) 15 mol% DSPE–PEG–biotin. The inset to (B) shows a microbubble
with single lipoplexes on its surface.
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2.3. Gene Transfer Efficiency of Lipoplex-Bearing
Microbubbles
The gene transfer efficacies of PEGylated lipoplexes, a
(physical) mixture of PEGylated lipoplexes and microbubbles,
and the lipoplex-loaded microbubbles have been evaluated. As
shown in Figure 8 (white bars, part B), the higher the degree of
PEGylation of the lipoplexes, the lower their transfection ca-
pacity. Lipoplexes with a degree of PEGylation of 5 mol% are
only slightly better than naked DNA (part A in Fig. 8),
whereas lipoplexes with a degree of PEGylation of 15 mol%
show almost no transfection. The failure of highly PEGylated
lipoplexes to transfect cells is in agreement with results of
other research groups, and has been ascribed to both a reduced
cellular uptake[20] and an inhibition of the endosomal release
of DNA into the cytoplasm by the PEG lipids in the lipo-
plexes.[21–25] Figure 8 (grey bars, part B) also shows data for the
transfection of cells when they are exposed to a (physical) mix-
ture of PEGylated lipoplexes using microbubbles and ultra-
sound. Since the ultrasound energy itself does not alter the
physicochemical properties of the PEGylated lipoplexes (see
discussion above), it is reasonable to expect that the transfec-
tion of the cells should at least be similar to that observed when
only free PEGylated lipoplexes are used (white bars, part B of
Fig. 8). However, we hypothesize that the strong decrease in
gene transfer observed for the 2 mol% PEGylated lipoplexes
arises from an ultrasound-induced blockage of endocytosis,
which is line with previous observations by Schlicher et al.[16]
They have shown that ultrasound treatment in the presence of
microbubbles removes patches of the plasma membrane; these
are subsequently resealed by lipid vesicles transported from
the inside of the cell to the plasma membrane (exocytosis). The
endocytosis of the cells, which is the major mechanism for the
uptake of the lipoplexes, may be significantly altered upon ex-
posure to ultrasound irradiation. Such repair mechanisms of
the cell membrane may prevent the endocytotic uptake of the
lipoplexes.[26] Figure 8 (grey bars, part B) shows that the pres-
ence of microbubbles and the application of ultrasound does
not really reduce the transfection properties of 5 and 15 mol%
PEGylated lipoplexes. Since the 5 and 15 mol% PEGylated li-
poplexes are much less endocytozed by the cells, it is reason-
able to expect that the (negative) influence of ultrasound and
microbubbles will be much less pronounced. Importantly, Fig-
ure 8 (black bars, part B) clearly shows that the attachment of
the lipoplexes to the microbubbles tremendously increases the
transfection efficiency of the 5 mol%, and especially the
15 mol%, PEGylated lipoplexes. As noted above, free PEGyl-
ated lipoplexes encounter difficulties in entering the cells and/
or in escaping from endosomes, especially when they are highly
PEGylated.[20,22–25] We hypothesize that most of the PEGylated
lipoplexes released from the microbubbles do not enter the
cells by endocytosis, and consequently do not have to escape
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Figure 5. Sizes of PEGylated lipoplexes containing 2, 5, and 15 mol%
DSPE–PEG–biotin before attachment to the microbubbles (white bars)
and after ultrasound-mediated release from the microbubbles (black
bars). The data represent the mean of three independent measurements
and the error bars indicate the standard deviation.
Figure 6. Zeta potential of PEGylated lipoplexes containing 2, 5, and
15 mol% DSPE–PEG–biotin before attachment to the microbubbles
(white bars) and after ultrasound-mediated release from the microbubbles
(black bars). The data represent the mean of three independent measure-
ments and the error bars indicate the standard deviation.
Figure 7. Gel electrophoresis of PEGylated lipoplexes containing 2, 5, and
15 mol% DSPE–PEG–biotin: A) before attachment to the microbubbles
and B) after ultrasound-mediated release from the microbubbles.
A) Lane 1: free pDNA; Lanes 2–4: PEGylated lipoplexes prepared with in-
creasing amounts of DSPE–PEG–biotin, 2, 5, and 15 mol%, respectively.
B) Lane 5: free pDNA; Lanes 6–8: PEGylated lipoplexes prepared with in-
creasing amounts of DSPE–PEG–biotin, 2, 5, and 15 mol%, respectively.
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from the endosomes. To verify this hypothesis, we have studied
the cellular uptake of the 15 mol% PEGylated lipoplexes after
exposure to ultrasound. Figure 9 shows a massive internaliza-
tion of the fluorescently labeled 15 mol% PEGylated lipo-
plexes immediately after exposure of the melanoma cells to
lipoplex-loaded microbubbles and ultrasound. As mentioned
above, several groups have reported the formation of transient
cell membrane perforations upon the implosion of microbub-
bles at or near cell membranes.[15,16,27,28] Consequently, it is rea-
sonable to expect that the PEGylated lipoplexes released from
the microbubbles enter the cells through these perforations,
explaining their rapid internalization in Figure 9. Since the life-
time of the cell membrane perforations is very short,[15] it is im-
portant that the lipoplexes are closely located to the cell mem-
brane perforations, which is indeed the case when they are
attached to the microbubbles. This phenomenon most likely
also explains why the physical mixing of the PEGylated lipo-
plexes with the microbubbles does not dramatically enhance
gene transfer (grey bars, part B), since most of the PEGylated
lipoplexes are not located close to the microbubbles. As indi-
cated by the arrow in Figure 8, the transfection efficiency of
the lipoplex-loaded microbubbles increases as a function of the
amount of DSPE–PEG–biotin in the lipoplexes. This can be
explained as follows: firstly, more PEGylated lipo-
plexes are attached to the microbubbles when the
lipoplexes contain more DSPE–PEG–biotin, which
results in an increased concentration of PEGylated
lipoplexes at the cell membrane perforations. Sec-
ondly, we note that the higher the degree of PEGyla-
tion, the smaller the size of the lipoplexes released
from the microbubbles, which increases the chances
of more PEGylated lipoplexes passing through the
cell perforations. Finally, when no ultrasound is ap-
plied, the cell transfection by lipoplex-loaded micro-
bubbles is negligible, and even lower than the trans-
fection by free PEGylated lipoplexes (data not
shown). This is again reasonable since without ultra-
sound the lipoplexes remain attached to the microm-
eter-sized bubbles that are too large to enter the cells.
Interestingly, this may enable the microbubbles to
transfect only those cells that are exposed to ultra-
sound energy, which may be promising for targeted
in vivo gene delivery.
3. Conclusions
We have designed a novel lipid microbubble to
which PEGylated lipoplexes are attached via biotin–
avidin–biotin linkages. Upon exposure to ultrasound,
unaltered lipoplexes are released from these lipo-
plex-loaded microbubbles. This is in contrast to pre-
viously developed layer-by-layer coated microbub-
bles, which lead to the release of undefined DNA-
containing clusters that are too large to pass through
the small cell perforations.[29] The lipoplex-loaded
microbubbles have a much higher gene transfer ca-
pacity than “free” PEGylated lipoplexes and naked pDNA
used in combination with microbubbles and ultrasound. Inter-
estingly, the lipoplex-loaded microbubbles only transfect cells
when exposed to ultrasound, which is promising for space- and
time-controlled gene transfer.[30,31] Thus far, the lack of gene
transfer has impeded the clinical evaluation of PEGylated lipo-
plexes. To the best of our knowledge, we have demonstrated
for the first time that gene transfer by lipoplexes containing
> 5 mol% PEG–lipid can be strongly improved by attaching
them to microbubbles and exposing them to ultrasound energy.
The microbubbles presented in this study are also expected to
be suitable for systemic applications. Indeed, microbubbles are
already routinely injected in the clinic to enhance the ultra-
sound-mediated visualization of blood vessels, whereas highly
PEGylated lipoplexes are known not to aggregate in blood and
have been shown to be harmless.[4,5] Moreover, this novel
Trojan-horse-like concept can be used to achieve the ultra-
sound-controlled delivery of drug-loaded liposomes by simply
attaching the drug-loaded liposomes or nanoparticles to the
microbubbles. In this way, a more targeted delivery of drug-
loaded nanoparticles can be achieved, resulting in an increase
of the therapeutic index of the drugs.
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Figure 8. A) The transfection efficiency of naked DNA in the absence and presence of
microbubbles and ultrasound, and the background luciferase signal in untreated cells.
B) The transfection efficiency of free PEGylated lipoplexes in the absence and presence
of microbubbles and ultrasound, and that of lipoplex-loaded microbubbles in the pres-
ence of ultrasound. The transfection results, i.e., the extent of luciferase expression,
are expressed as RLUmg–1 (RLU: relative light units) protein. * p< 0.05, compared to
lipoplexes or naked DNA without microbubbles and ultrasound. **p< 0.05.
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4. Experimental
Preparation and Characterization of Lipid Microbubbles Containing
DSPE–PEG–Biotin: Liposomes containing DPPC/DSPE–PEG–biotin
in a 95:5 molar ratio were prepared as previously described [32].
Briefly, the lipids dissolved in chloroform were placed in a round-bot-
tomed flask and the solvent was removed by evaporation followed by
flushing with nitrogen. The obtained lipid film was subsequently hy-
drated in a 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid
(HEPES) buffer solution (20 mM HEPES, pH7.4) at a final lipid con-
centration of 5 mgmL–1; the film was incubated overnight in this solu-
tion at 4 °C to allow the formation of liposomes. The resulting lipo-
somes were first extruded through a polycarbonate membrane (pore
size of 0.2 lm) using a mini-extruder (Avanti Polar Lipids, Alabaster,
AL, USA). Subsequently, the extruded liposomes were sonicated with
a 20 kHz probe (Branson 250 sonicator, Branson Ultrasonics, Danbury,
CT, USA) in the presence of perfluorobutane gas (C4F10, molecular
weight (MW) 238 gmol–1, F2 Chemicals, Preston, Lancashire, UK).
After sonication, the microbubbles were washed (to remove excess lip-
ids) with 3 mL fresh HEPES buffer, and finally resuspended in 5 mL
of a fresh HEPES buffer solution. To allow the attachment of biotinyl-
ated lipoplexes, the biotinylated microbubbles were incubated with
500 lL avidin (10 mgmL–1) for 10 min at room temperature. Subse-
quently, the microbubbles were centrifuged and washed again with
3 mL fresh HEPES buffer. Finally, the microbubbles were resuspended
in a 5 mL HEPES buffer solution. The concentration of the avidiny-
lated microbubbles in the dispersions was determined with the aid of a
Burker chamber and a light microscope, and was found to be
4× 108 microbubblesmL–1. The size distribution of the microbubbles
was determined within 10 min of preparation by laser diffraction (Mas-
tersizer S, Malvern, Worcestershire, UK). To measure the size distribu-
tion of the lipoplex-loaded microbubbles, 130 lL of the 15 mol%
DSPE–PEG–biotin-containing lipoplexes was incubated for 5 min with
1 mL of the microbubble suspension and the measurement was per-
formed again. The results are expressed as number percentages nor-
malized to the most abundant fraction of microbubbles. All these ex-
periments were performed using microbubbles dispersed in HEPES
buffer. For the visualization of avidin on the surface of the biotinylated
microbubbles, we incubated the microbubbles with 50 lL of Cy5-la-
beled streptavidin (1 mgmL–1).
Preparation and Characterization of PEGylated Cationic Liposomes
and Lipoplexes: The phospholipids, N-(1-(2,3-dioleoyloxy)propyl)-
N,N,N-trimethylammonium chloride (DOTAP), dioleoyl phosphatidyl
ethanolamine (DOPE), DSPE–PEG, DSPE–PEG–biotin, and choles-
teryl 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-dode-
canoate (cholesteryl Bodipy FLC12) were purchased from Avanti Polar
Lipids. Cationic liposomes containing DOTAP/DOPE in a 1:1 molar
ratio with 0.1 mol% cholesteryl Bodipy FLC12 and 0 to 15 mol%
DSPE–PEG or DSPE–PEG–biotin were prepared as described above.
For the preparation of lipoplexes, we used pDNA (pGL3, Promega,
Leiden, The Netherlands) containing the luciferase gene from Photi-
nus pyralis as the reporter. The pDNAwas amplified in Escherichia co-
li and purified as described elsewhere [32]. The pDNA concentration
was set at 1.0 mgmL–1 in HEPES buffer taking into account that the
absorption of a 50 lgmL–1 DNA solution at 260 nm equals 1. The
pDNA was of high purity as evidenced by the ratios of the optical ab-
sorptions at 260 and 280 nm varying from 1.8 to 2.0. Lipoplexes (with
different percentages of DSPE–PEG or DSPE–PEG–biotin) were pre-
pared with a charge ratio of 4. The charge ratio is defined as the ratio
of the number of the positive charges (originating from DOTAP) to
the number of the negative charges (originating from the pDNA).
pDNA was first diluted in HEPES buffer to a concentration of
0.41 mgmL–1. Subsequently, the diluted pDNA was added to an equal
volume of cationic liposomes (5 mM DOTAP), resulting in a final +/–
charge ratio of 4. Immediately after the addition of pDNA to the cat-
ionic liposomes, HEPES buffer was added until the final concentration
of pDNA in the system was 0.126 mgmL–1. This mixture was then vor-
texed and incubated at room temperature for 30 min. To obtain green-
labeled lipoplexes, liposomes prepared with 0.5 mol% of cholesteryl
Bodipy FLC12 were used. The average hydrodynamic diameter of the
PEGylated lipoplexes was determined by DLS (Autosizer 4700, Mal-
vern). The data were analyzed using the automatic data analysis mode,
i.e., a monomodal fit was used when the polydispersity (PD) was < 0.05
and a continuous fit was used when the PD was > 0.05. The zeta poten-
tial (f) was determined using electrophoretic mobility measurements
(Malvern Zetasizer Nano ZS, Malvern). For these experiments, the li-
poplexes were dispersed in HEPES buffer. The size and zeta potential
of lipoplexes released from the lipoplex-loaded microbubbles after ex-
posure to ultrasound (1 MHz, 10% duty cycle) for 10 s were deter-
mined in a similar way. Gel electrophoresis experiments were per-
formed following previously described protocols [32] to determine the
presence of free pDNA in the lipoplexes before binding to the micro-
bubbles and after ultrasound-assisted release from the microbubbles.
Attachment of Biotinylated PEG-Lipoplexes to Avidinylated Micro-
bubbles: 130 lL of a solution of biotinylated PEG-lipoplexes was
mixed with a 1 mL solution of avidinylated mirobubbles and incubated
at room temperature for 5 min. The attachment of fluorescent-labeled
lipoplexes to the microbubbles was visualized by CLSM using a Nikon
EZC1-si microscope (Nikon, Brussels, Belgium) equipped with a 40×
objective. The 491 nm line of this microscope was used to excite the
Bodipy label.
Transfection Experiments: BLM cells (melanoma cells) [33] were cul-
tured in Dulbecco’s modified Eagle’s medium (DMEM) with the
growth factor F12 and phenol red containing 2 mM glutamine, 10%
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Figure 9. Cellular uptake of green-labeled 15 mol% PEGylated lipoplexes
in BLM cells immediately after exposure of the cells to lipoplex-loaded mi-
crobubbles and ultrasound. A–D) Transmission images and B–E) CLSM
images of green-labeled lipoplexes; C–F) overlays of the transmission and
the green fluorescent confocal images. D–F) High-magnification images
of a single cell.
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heat-deactivated fetal bovine serum (FBS), 1% penicillin–streptomy-
cin (Gibco, Merelbeke, Belgium), and HEPES buffer (100 mM,
pH7.4). The cells were grown to 90% confluency in Opticell units
(Biocrystal, Westerville, OH, USA) inside a humidified incubator at
37 °C under 5% CO2. Subsequently, the cells were washed with 10 mL
of phosphate buffered saline (PBS, Gibco) and the transfection medi-
um was added. The transfection media were prepared by first mixing
130 lL PEGylated lipoplexes with 1 mL of the microbubble suspen-
sion (containing 4× 108 microbubbles). After incubation for 5 min at
room temperature, optimem (Gibco) was added to a final volume of
10 mL. The transfection medium was prepared in a similar way for
transfection experiments with naked pDNA, except that the 130 lL so-
lution of the PEGylated lipoplexes was replaced by an equal volume of
HEPES buffer containing 16.5 lg pDNA, the same amount as present
in the lipoplexes. 10 mL of the transfection medium was added to the
Opticell units (surface area of 50 cm2). Subsequently, the cells were
placed in a water bath at 37 °C with an absorbing rubber substrate at
the bottom and immediately subjected to ultrasound irradiation. The
ultrasound irradiation was performed for 10 s with a Sonitron 2000 in-
strument (RichMar, Inola, OK, USA) equipped with a 22 mm probe.
In all the ultrasound-assisted experiments, the following ultrasound set-
tings were used: 1 MHz, 10% duty cycle, and an ultrasound intensity
of 2 Wcm–2. The areas treated with ultrasound were marked and after
irradiation the Opticells were incubated for an additional 2 h at 37 °C.
At the end of this incubation period, the transfection medium was re-
moved and the cells were washed two times with PBS, before adding
fresh culture medium. Each transfection experiment was performed
three times. Luciferase expression by the cells was analyzed 24 h after
transfection. The culture medium was removed and the cells were
washed with PBS. The areas exposed to ultrasound (20 mm diameter)
were cut from the Opticell membrane and placed in a 24 well plate. A
80 lL solution of cell culture lyse reagent (CCLR, Promega, Leiden,
The Netherlands) buffer was added to each well and incubated at room
temperature for at least 20 min to allow cell lysis. 20 lL of the cell ly-
sate was transferred to a 96 well plate and the luciferase activity was
measured using a Glomax 96 Microplate Luminometer (Promega), as
described previously in the literature [34]. An aliquot (20 lL) of each
cell lysate was also analyzed for protein concentration using the bichin-
coninic acid (BCA) protein assay (Pierce, Rockford, IL, USA). The
transfection results are expressed as relative light units (RLU) per
milligram of protein.
Cellular Uptake of Green-Labeled 15 mol% DSPE–PEG–Biotin-
Containing Lipoplexes: Bodipy-labeled lipoplexes containing 15 mol%
DSPE–PEG–biotin were prepared and attached to the microbubbles as
described above. BLM cells present in Opticell units were exposed to
the lipoplex-loaded microbubbles and ultrasound using the same condi-
tions as in the transfection experiments. The areas treated with ultra-
sound were immediately visualized by CLSM using a Nikon EZC1-si
microscope equipped with a 60 × objective. The 491 nm line of this mi-
croscope was used to excite the Bodipy label in the lipoplexes.
Statistical Analysis: All the data in this report are expressed as
mean± standard deviation (SD). For the transfection results, the stu-
dent’s t-test was used to determine whether the data groups differed
significantly from each other. A p-value lower than 0.05 was considered
statistically significant.
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